Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A(1) chieve study

AIM: To determine the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) therapy in the Indian patients with type 2 diabetes previously on basal or basal-bolus insulin therapies. MATERIALS AND METHODS: Patients switching from insulin glargine, neutral protamine Hagedorn (NPH) insulin, or b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Arpandev, Shetty, Raman, Rajkumar, C, Bantwal, Ganapathi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138901/
https://www.ncbi.nlm.nih.gov/pubmed/25143902
http://dx.doi.org/10.4103/2230-8210.137490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138901/
https://www.ncbi.nlm.nih.gov/pubmed/25143902
http://dx.doi.org/10.4103/2230-8210.137490

Ejemplares similares